The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
Recruiting now
Conditions studied: Primary Pulmonary Lymphoepithelioma-like Carcinoma
In brief
This retrospective case-control study aims to investigate the genetic mechanisms of primary Pulmonary Lymphoepithelioma-like Carcinoma, identify genetic susceptibility loci associated with its onset, and explore potential pathogenic genes, providing new insights for its etiological research.
Key facts
- Study ID
- NCT06801977
- Run by
- Sun Yat-sen University
- People needed
- 10000
- Starts
- 2002-01-01
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2025-01-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- The subject is pathologically diagnosed with primary pulmonary lymphoepithelioma-like carcinoma.
You may not qualify if…
- The subject is diagnosed with metastatic nasopharyngeal carcinoma; The subject has heavy cardiovascular, liver, or kidney disease.
- Controls:
- Inclusion criteria:
- The subject is in good physical condition and has a stable level of consciousness;
- Exclusion criteria:
- The subject has prevalent cancer; The subject has heavy cardiovascular, liver, or kidney disease.
Where it is running
- Foshan First People's Hospital — Foshan, Guangdong, China (enrolling)
- Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.